Jan-Peter Ingwersen

Title: Innovator Spotlight: Jan-Peter Ingwersen, Pioneering Transdermal Therapeutic Plasters

Introduction:

Jan-Peter Ingwersen, a renowned inventor based in Berlin, DE, has made significant contributions to the field of transdermal therapeutic systems (TTS) with his innovative patents. With a total of 5 patents to his name, Ingwersen has revolutionized the medical industry with his groundbreaking inventions.

Latest Patents:

One of Ingwersen's latest patents is the UV stable transdermal therapeutic plaster with a UV absorbing self-adhesive layer separated from the drug matrix. This patent introduces a novel TTS design that enhances stability and eliminates issues associated with light-sensitive substances. By incorporating a UV-radiation absorber into the adhesive layer, Ingwersen's invention sets a new standard for transdermal drug delivery systems.

Career Highlights:

Ingwersen has a rich professional background, having worked at prestigious companies such as Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. His tenure at these renowned organizations has provided him with the expertise and resources to drive innovation in the pharmaceutical and medical device sectors.

Collaborations:

Throughout his career, Ingwersen has collaborated with top-notch professionals in the industry, including Doris Hubler and Sabine Fricke. Together, they have spearheaded research and development projects that have led to the successful implementation of cutting-edge medical technologies.

Conclusion:

In conclusion, Jan-Peter Ingwersen stands out as a trailblazing inventor in the realm of transdermal therapeutic systems. His dedication to advancing drug delivery mechanisms and improving treatment outcomes underscores his commitment to innovation and excellence in the medical field. Ingwersen's inventive spirit continues to inspire future generations of inventors and researchers in their quest to enhance healthcare solutions worldwide.